Skip to content

The usefulness of measuring lung water content in managing patients after cardiovascular surgery for congenital heart disease

Phase II Trial Examining the Efficacy of Lung Water Content Measurement Using ReDS Pro in the Management of Heart Failure After Cardiovascular Surgery - Phase II trial of ReDS on CVS postoperative management

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs062240090
Enrollment
100
Registered
2024-12-11
Start date
2025-04-04
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiovascular disease cardiovascular disease

Interventions

Measurement of water content of lung using ReDS Pro

Sponsors

Fujii Yasuhiro
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: This study targets individuals who meet all of the following criteria: 1) Individuals who are at least 140 cm in height at the time of consent acquisition (age is not considered). 2) Individuals who, after receiving a comprehensive explanation regarding participation in this study, have demonstrated a sufficient understanding and have provided written consent freely of their own volition. 3) A person who has obtained consent from a surrogate.

Exclusion criteria

Exclusion criteria: The following criteria will exclude individuals from participating in this study 1. Inability to perform measurements due to patient refusal or the following conditions Deformity of the chest History of thoracic surgery Recent surgical wounds, healing tissues, or recent skin grafts/ flaps on the chest Osteoporosis or osteomyelitis of the ribs Presence of pain in the chest wall Presence of implanted metal devices, such as pacemakers, between the ReDS Pro and the chest 2. Any other condition that the principal investigator or sub-investigators deem unsuitable for study participation

Design outcomes

Primary

MeasureTime frame
Post-operative hospital stay

Secondary

MeasureTime frame
Number of complication events requiring treatment: heart failure, infection, vascular events

Contacts

Public ContactMariko Koshiba

Okayama University

piff27xn@okayama-u.ac.jp+81-86-2357-7359

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026